|
BTRC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7519319328585E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.79760026045528E-10 |
| Normal-vs-Stage2 |
5.76509999961061E-07 |
| Normal-vs-Stage3 |
2.30170327242263E-11 |
| Normal-vs-Stage4 |
3.05211411699702E-12 |
| Stage1-vs-Stage2 |
9.953400E-01 |
| Stage1-vs-Stage3 |
4.013700E-02 |
| Stage1-vs-Stage4 |
1.778060E-04 |
| Stage2-vs-Stage3 |
1.375220E-01 |
| Stage2-vs-Stage4 |
2.604000E-03 |
| Stage3-vs-Stage4 |
1.023410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.91668944341473E-14 |
| Normal-vs-AfricanAmerican |
5.954500E-04 |
| Normal-vs-Asian |
1.42469999997452E-06 |
| Caucasian-vs-AfricanAmerican |
2.815000E-01 |
| Caucasian-vs-Asian |
2.265400E-01 |
| AfricanAmerican-vs-Asian |
8.623800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.25529619821441E-11 |
| Normal-vs-Female |
3.24784643623843E-12 |
| Male-vs-Female |
4.885000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6726999785277E-09 |
| Normal-vs-Age(41-60Yrs) |
6.53529452776525E-11 |
| Normal-vs-Age(61-80Yrs) |
7.05929759092783E-11 |
| Normal-vs-Age(81-100Yrs) |
2.421300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.400600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.357580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.593190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.097200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.939800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.827600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.58350000000796E-05 |
| Classical-VS-Follicular |
8.152600E-01 |
| Classical-VS-Other |
4.620000E-01 |
| Classical-VS-Normal |
4.30719999666707E-08 |
| Tall-VS-Follicular |
7.556500E-04 |
| Tall-VS-Other |
3.098400E-01 |
| Tall-VS-Normal |
3.00470759384552E-12 |
| Follicular-VS-Other |
5.016800E-01 |
| Follicular-VS-Normal |
1.23090000003767E-06 |
| Other-VS-Normal |
4.937600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.79730016927715E-10 |
| Normal-vs-N1 |
4.80382400525059E-12 |
| N0-vs-N1 |
5.021800E-03 |
|
|
